Summit Therapeutics Inc
NASDAQ:SMMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Summit Therapeutics Inc
NASDAQ:SMMT
|
US |
|
Worldline SA
PAR:WLN
|
FR |
|
L
|
Lagardere SA
XMUN:LAG
|
FR |
|
B
|
Blue Label Telecoms Ltd
XMUN:5TP
|
ZA |
|
Titan Cement International SA
F:TCJ
|
BE |
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
U
|
United Labels AG
XBER:ULC
|
DE |
|
Nan Ya Plastics Corp
TWSE:1303
|
TW |
|
Halma PLC
LSE:HLMA
|
UK |
|
C
|
China State Construction International Holdings Ltd
XMUN:C4S1
|
HK |
|
Shriram Transport Finance Company Ltd
NSE:SRTRANSFIN
|
IN |
|
SIG Group AG
OTC:SCBGF
|
CH |
|
Alexandria Group Oyj
F:3ZL
|
FI |
|
Westwing Group SE
F:WEW
|
DE |
|
T
|
Titan Cement International SA
ATHEX:TITC
|
BE |
|
Regions Financial Corp
NYSE:RF
|
US |
|
China State Construction International Holdings Ltd
HKEX:3311
|
HK |
Wall St Price Targets
SMMT Price Targets Summary
Summit Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SMMT is 30.98 USD with a low forecast of 9.9 USD and a high forecast of 47.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SMMT's stock price target?
Price Target
30.98
USD
According to Wall Street analysts, the average 1-year price target for
SMMT is 30.98 USD with a low forecast of 9.9 USD and a high forecast of 47.25 USD.